Related Experiment Videos
Inhibition of poly(2'-fluoro-2'-deoxyadenylic acid)-directed-reverse transcriptase activity
1Departamento de Bioquimica, Universidade Estadual de Campinas, São Paulo, Brasil.
Journal of Enzyme Inhibition
|January 1, 1995
Summary
This study investigated how various drugs inhibit avian myeloblastosis virus (AMV) reverse transcriptase. Ethidium bromide showed higher inhibition, particularly with poly(rA) templates, while other drugs like berenil were more effective with modified templates.
Area of Science:
- Biochemistry
- Molecular Biology
- Virology
Background:
- Avian myeloblastosis virus (AMV) reverse transcriptase is crucial for viral DNA synthesis.
- Understanding drug inhibition mechanisms is key for antiviral development.
- Intercalating and nonintercalating drugs exhibit varied effects on enzyme activity.
Purpose of the Study:
- To evaluate the inhibitory effects of different drugs on AMV reverse transcriptase.
- To compare drug efficacy using natural poly(rA) and modified poly(dAfl) templates.
- To elucidate the inhibition kinetics and mechanisms.
Main Methods:
- Enzyme inhibition assays using purified AMV reverse transcriptase.
- Employing polyriboadenylic acid (poly(rA)) and poly(2'-fluoro-2'-deoxyadenylic acid) (poly(dAfl)) as templates.
- Kinetic analysis of drug inhibition, including competitive and non-competitive interactions.
Main Results:
- Ethidium bromide, an intercalating drug, showed higher inhibition than its analog, tetramethyl ethidium bromide.
- Ethidium bromide was more potent with poly(rA) templates; inhibition was non-competitive with TTP for poly(dAfl).
- Non-intercalating drugs (berenil, netropsin, distamycin) more effectively inhibited the poly(dAfl)-directed reaction.
Conclusions:
- Drug efficacy against AMV reverse transcriptase is template-dependent.
- Intercalating and non-intercalating drugs possess distinct inhibition profiles.
- These findings contribute to understanding antiviral drug interactions with reverse transcriptase.